Nothing lasts forever: Proposed ban of PFAS in the EU
Emma Bichet and Selma Abdel-Qader
The proposed EU restriction of per-and polyfluoroalkyl substances was published on 7 February 2023. If adopted into law, the restriction will result in a ban on the manufacture, use and placing on the EU market of around 10,000 PFAS,
EMA to reinstate its proactive clinical data publication policy
EMA has decided to restart implementation of its policy to proactively publish clinical data.
REACH for the stars!
Emma Bichet, Carol Holley and Selma Abdel-Qader
Cooley’s Productwise Bitesize brings you a short introduction to the REACH Regulation.
New applications for approval of clinical trials to be submitted in accordance with the CTR starting on 31 January 2023
Use of CTIS for new clinical trial applications becomes mandatory on 31 January 2023.
New EU rules on the design and production of batteries published
Ed Turtle, Tracey Bischofberger and Selma Abdel-Qader
After lengthy negotiations, the ‘final’ text of the EU Batteries Regulation agreed between the European Commission, Parliament and Council has been published. Whilst it’s possible there could still be minor changes, you can expect this to be substantively the same as the final published legislation.
Productwise Bitesize: The Cosmetic Products Regulation
Emma Bichet, Harriet Jones and Selma Abdel-Qader
Cooley’s Productwise Bitesize brings you a short introduction to the Cosmetic Products Regulation.
The clock is ticking – feedback period for new EU cyber rules ends soon
Claire Temple, Emma Bichet and Selma Abdel-Qader
Productwise guides you through the European Commission’s new initiative on cybersecurity requirements.
EMA guideline on sponsor responsibility for release and shipping of IMPs in accordance with GCP and GMP in the EU comes into effect
Read an overview of the EMA guideline on clinical trial sponsor responsibility for management of IMPs
The EMA publishes updated Q&A on clinical trial sponsor oversight of delegated tasks
Read a summary of EMA’s updated guidance on how clinical trial sponsors can demonstrate oversight of activities delegated to third party service providers.
European Commission publishes updated Q&A on the Clinical Trials Regulation
Read a summary of the updated version of the Q&A guidance on the Clinical Trials Regulation.